Unlock instant, AI-driven research and patent intelligence for your innovation.

Dendrimer gemcitabine self-assembled nanometer prodrug, and preparation method and application thereof

A technology of gemcitabine and dendrimers, which is applied in the field of dendrimer gemcitabine self-assembled nano-prodrugs and its preparation, can solve the problems of difficult regulation and optimization of drug ratios and limitations of wide application, and achieve rich surface groups and broad application prospects , the effect of high drug loading

Active Publication Date: 2020-06-19
XINXIANG MEDICAL UNIV
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the design and preparation of SAPDs usually varies from drug to drug, depending on the chemical structure of the drug. The preparation of SAPDs for each drug requires selection of an appropriate assembly strategy and rational molecular design, and the ratio of drugs is difficult to control and optimize. To a certain extent, the wide application of such delivery systems is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dendrimer gemcitabine self-assembled nanometer prodrug, and preparation method and application thereof
  • Dendrimer gemcitabine self-assembled nanometer prodrug, and preparation method and application thereof
  • Dendrimer gemcitabine self-assembled nanometer prodrug, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1: Preparation of the second-generation azide-terminated dendrimer with C18 long chain as the hydrophobic part

[0049] In the first step, weigh 99.8mg (0.11mmol) of the amphiphilic dendrimers at the end of the disubstituted ester group, add 5.0mL of methanol to dissolve it, then add 1.0mL (15mmol) of ethylenediamine under stirring, and stir the reaction at 30°C After 72 hours of reaction, an appropriate amount of methanol was added, and the mixture was spin-dried under reduced pressure to obtain an oily liquid, which was settled three times with methanol / ether to obtain a dendrimer product (101.8 mg, 91%) with amino terminal modification.

[0050] In the second step, weigh 105 mg (0.6 mmol) of azidesulfonylimidazole, add 4.0 mL of a mixed solvent of methanol and acetonitrile to dissolve it, and then add 78 mg (0.075 mmol) of dendrimers at the end of the amino group, CuSO 4 ·5H 2 O (3.0mg, 5.0mol%) and K 2 CO 3 (83mg, 0.60mmol), stirred at room temperature fo...

Embodiment 2

[0052] Embodiment 2: the synthesis of the gemcitabine prodrug containing alkyne bond

[0053] In the first step, 263 mg (1.0 mmol) of gemcitabine was weighed and dissolved in 5 mL of DMF, then 603 mg (4 mmol) of TBSCl and 272 mg of imidazole were added to the reaction system overnight, and 30 mL of distilled water was added to quench the reaction, extracted with ethyl acetate, 15 mL each time, Extracted 3 times, combined extracts, dried over anhydrous sodium sulfate, concentrated under reduced pressure, separated by silica gel column chromatography, and eluted with dichloromethane / methanol gradient to obtain 310 mg of white solid with a yield of 63.3%.

[0054] In the second step, 59.6mg (0.6mmol) of 4-pentynoic acid, 191.3mg (1.0mmol) and 135.8mg (1.0mmol) of HOBt were dissolved in 4.5mL THF, stirred in an ice bath for 30min, and the 4' prepared in the first step was added. and 250 mg (0.5 mmol) of gemcitabine protected at the 5' position, stirred at room temperature, monitor...

Embodiment 3

[0056] Example 3: Preparation of the second-generation dendrimer-gemcitabine amphiphilic prodrug with C18 long chain as the hydrophobic part

[0057] Weigh the gemcitabine prodrug containing alkyne bond (41.5mg, 0.12mmol), CuSO 4 ·5H 2 O (2.4 mg, 10 mol%) and sodium ascorbate (2.6 mg, 15 mol%), followed by addition of terminal azide-modified dendrimers, tetrahydrofuran and water under a nitrogen atmosphere, stirred at 60 ° C for 5 h, then concentrated and added CH 2 Cl 2 / Et 2 O was settled overnight, and further purified by silica gel column chromatography, gradient elution with ethyl acetate / methanol (volume ratio 2:1-1:3), to obtain 19.7 mg of white solid, with a yield of 39.4%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a dendrimer gemcitabine self-assembled nano prodrug, and a preparation method and application thereof. Firstly, different hydrophobic ends or hydrophilic ends are used for synthesizing tail end azide modified amphipathic dendrimers; meanwhile, gemcitabine prodrug molecules containing acetylene bonds are prepared; products in the first two steps are connected through "azide-acetylene" click reaction to obtain an amphipathic dendrimer gemcitabine prodrug; and finally, nanometer prodrug particles are prepared through a dialysis self-assembly method. The microstructure andenzyme stability of the nanometer particles are studied; cellular uptake and mouse in vivo experiments are further performed; the result proves that the self-assembled nanometer prodrug can obviouslyimprove the metabolic stability and anti-tumor activity of a prototype drug of gemcitabine; the problems of great toxic and side effects and the like of a parent micromolecular drug of gemcitabine can be solved; and the basic experiment basis can be provided for clinic application.

Description

technical field [0001] The invention belongs to the technical field of nanometer drug delivery system, and in particular relates to a dendrimer gemcitabine (Gemcitabine) self-assembled nanometer prodrug and its preparation method and application. Background technique [0002] Gemcitabine (formula I), entered the market with FDA approval in 1996, is a first-line drug for the treatment of advanced non-small cell lung cancer and pancreatic cancer, and is also used for the treatment of malignant tumors such as breast cancer, ovarian cancer, and nasopharyngeal cancer (Biomed.Pharmacother. 2017, 88, 635.). However, gemcitabine is easily de-aminated at the 4-position by a large amount of deoxycytidine deaminase (CDA) in the liver and blood to generate an inactive product 2,2'-difluorodeoxyuridine, resulting in its metabolic stability Poor sex, very short half-life in the human body (<17min) (Eur.J.Pharm.Sci.2016,93,147.). Therefore, clinical practice usually requires continuou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/58A61K47/59A61K47/60A61K47/69A61K31/7068A61P35/00C07H1/00C07H19/073
CPCA61K47/58A61K47/60A61K47/595A61K47/6907A61K31/7068A61P35/00C07H19/073C07H1/00
Inventor 从梅赵伟栋杨景瑞徐广凌张静王智慧
Owner XINXIANG MEDICAL UNIV